USPTO serial 78246754
EFFIPURE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- RUPP, TERRY
- Law office
- TMEG LAW OFFICE 106 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with EFFIPURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Douglas R. Wolf
DOUGLAS R WOLF WOLF, GREENFIELD & SACKS PC600 ATLANTIC AVEBOSTON, MA 02210UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Gel cassettes for use in clinical and medical applications used in the field of medicine with a base, safety cover, comb, electrode and electrical power supply; and optical scanners and computer software for use in clinical and medical applications in the field of medicine | ACTIVE | — |
| 010 | Gel cassettes for use in clinical and medical applications used in the field of medicine without a base, safety cover, comb, electrode and electrical power supply; Micro array reagents for use in clinical and medical applications used in the field of medicine; Reagents, namely micro arrays for clinical medical use; Reagents, namely gel cassettes for clinical or medical use in electrophoresis assays; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting analysts; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in purifying analytes analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in separating analytes; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting nucleic acid sequences; Reagents for clinical medical diagnostic electrophoresis assays, namely gel cassettes for use in purifying nucleic acid secluences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in separating nucleic acid sequences; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting bacterial contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting viral contamination in blood products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in detecting bacterial contamination in platelet products; Reagents for clinical medical use in diagnostic electrophoresis assays, namely gel cassettes for use in identifying bacterial pathogens; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect analytes; Reagent kits for clinical medical use, namely kits comprised of micro arrays and reagents; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to purify analytes;Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to separate analytes; Reagent kits for clinical medical use, namely kits comprised of gel cassettes and reagents use to detect nucleic acid sequences; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to purify nucleic acid sequences; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to separate nucleic acid sequences; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect contamination in blood products; Reagent kits for clinical medical use in diagnostic electrcphoresms assays, namely kits comprised of gel cassettes and reagents used to detect bacterial contamination in blood products; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect viral contamination in blood products; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect contamination in platelet products; Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to detect bacterial contamination in platelet products; and Reagent kits for clinical medical use in diagnostic electrophoresis assays, namely kits comprised of gel cassettes and reagents used to identify bacterial pathogens | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 30, 2005 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 30, 2005 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jun 17, 2005 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 17, 2005 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 3, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 18, 2005 | ALIE | ASSIGNED TO LIE | — |
| Feb 4, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 4, 2005 | PAPER RECEIVED | — | |
| Jan 2, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 2, 2004 | FAXX | FAX SENT | — |
| Aug 11, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 10, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| May 5, 2004 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 2, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 2, 2004 | PAPER RECEIVED | — | |
| Nov 17, 2003 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Nov 17, 2003 | PAPER RECEIVED | — | |
| Oct 10, 2003 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 7, 2003 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 6, 2003 | PAPER RECEIVED | — |